China equities: Why Stock Connect matters

We help you understand why the Hong Kong – China Stock Connect important for investors.

by China Equities team 15 Oct 2019

The low down on Stock Connect and China equities

  • Stock Connect has been a breakthrough and is a much more efficient way for overseas investors to access China compared to QFII and RQFII quota programs;
  • Stock Connect has opened up China's A-share markets, boosted equity investment flows both into and out of China;
  • The introduction of Stock Connect is the primary reason why A-shares have been included in global index benchmarks and why global investor inflows into mainland China equities have accelerated;
  • Because of Stock Connect and MSCI inclusion, we feel investors are changing the way they invest in China. That means considering allocating to China stocks on an All China basis, and also investing in China equities as a standalone investment class of its own.

Stock Connect was introduced to improve investor access, speed up trading processes, increase the role of overseas capital in China's equity markets, and provide an outlet to Hong Kong markets for investors in China. Against all these criteria, Stock Connect has been very successful indeed.

Before Stock Connect, investing in China A-shares from overseas was possible but challenging.

Programs like QFII and RQFII gave access to A-share markets but approval periods were lengthy, trading processes were time consuming, and execution could be restrictive, all of which were challenging for active investors like ourselves.

For example, it could take weeks to apply for all the necessary licenses and quotas stipulated by the QFII and RQFII schemes in the past.

QFII trading also came with strict controls on buying and selling, and trading was done on a 'no fail' basis, and all these aspects made QFII investing cumbersome, but capital control restrictions also applied lock-up periods and repatriation limits, which meant we would go through periods where we were out of the market, which obviously wasn't ideal for us.

Stock Connect was introduced to remove the lengthy approval processes for trading, make investing more efficient, and open up China's onshore equity markets to global investors, but it wasn't an overnight success.

In the initial period after Stock Connect launched, trading volumes were lower than we expected and much lower than the initial quotas set for the program.

It took time for investors to adjust to the new system and build confidence in it, partly because the initial trading models were not as efficient as it is now.

One big change was the introduction of special segregated accounts (SPSA) in 2015. Through that, investors got individual accounts in the Central Clearing and Settlement System and could link to multiple brokers. This marked a big step forward for investors and brought Stock Connect closer into line with other trading systems used both in Asia and globally.

As trading volumes have grown, regulators have expanded trading quotas too to boost trading and inflows. In 2018, the China Securities Regulatory Commission (CSRC) quadrupled daily quotas, boosting daily northbound quotas on the Shanghai and Shenzhen to RMB 52bn yuan (USD8.27 billion) from RMB 13bn before.

Put together, Stock Connect has created an additional route for China equity investing. While it remains a work in progress, the attitude we are seeing from regulators tells us that it will likely be expanded and improved in the future.

China A-share trading With Stock Connect is simpler and quicker than using QFII and RQFII and regulators have moved quickly to improve it over the years.

Stock Connect provides direct access to China's onshore markets, gives investors more choice of equity investment opportunities, allows investors to participate more fully in China's growth story, and opens up many opportunities for active strategies.

Exhibit4: Onshore/Offshore Markets Compared (No. of Stocks)

Investors get more choice of investible equities via Stock Connect.

If you only invest in China equity markets via H-shares or ADRs you have a relatively limited range of choices.

But Stock Connect gives investors access to a much wider range of stocks. That means a wider range of ways to participate in China's growth story and greater exposure to fast-growing, high-potential sectors like consumer and healthcare.

As important as quantity of opportunities, it's also about quality. Not every onshore company is included in Stock Connect but the ones that are included are, generally speaking, the best quality companies on the markets.

Finally, Stock Connect gives investors easier access to the onshore market that is still comparatively immature and inefficient, and that means a happy hunting ground for active investors like ourselves.

Though China's A-share markets have developed a great deal, they remain driven by retail investors, and that means they can be volatile and prone to mispricing.

That's a challenge for passive investors but an opportunity for active, fundamentally-driven investors because we can take advantage of mispricing, deviate from benchmarks, and allocate to the best opportunities wherever we see them, regardless of prevailing market sentiment.

We feel that Stock Connect means the old way of China equity investing no longer applies and that investors should consider an All China approach.

In the past, China equity investors used to allocate either to onshore or offshore markets. Now, these distinctions don't really apply anymore. Stock Connect means investors can now freely combine the best China equity opportunities wherever they are listed into one optimal portfolio.

This approach, which we call All China equity investing, is one which we think investors should be following now because, in time, it will be the way of the future.

We also feel that investors need to adapt their views of China in both global equity markets and the global economy.

After Stock Connect reduced barriers to onshore China equities, global index providers like MSCI and FTSE Russell realised that a major part of the global economy remained under-represented in their benchmarks.

As a result, these index providers have started the process of including China equities into their benchmarks to redress the balance.

As time goes on and index inclusion plays out, China's role in global benchmarks will evolve from being merely part of emerging markets to being a distinct, standalone category of its own.

This (overdue) evolution means investors must now consider China as a standalone allocation of its own, in much the same way that consider the US, UK, and Japan.

Stock Connect is changing China's equity markets and we feel the best way investors can adapt and take advantage is by considering China stocks from an All China perspective, and also allocating to China on a standalone basis.

Stock Connect has indirectly improved corporate governance, driven the adoption of ESG standards/reporting, shifted investor behaviors, and brought about the inclusion of China A-shares in global stock indexes, like MSCI and FTSE Russell.

Looking at corporate governance, international investors expect A-share companies to adhere to international standards. Since the launch of the program, we have seen notable progress in terms of corporate reporting and disclosure.

On a related note, we are seeing more companies issue ESG reports, and this is an increasing trend. In fact, this is going to become a mandatory, not an optional, practice because China has introduced legislation to enforce compulsory ESG disclosure for listed companies from 20206.

Additionally, China A share market becomes more fundamental driven, which we believe is down to more international money. Recent research by MSCI7 shows that fundamental factors like price-to-book and earnings quality have become much more influential in China's markets and we see that as a very welcome development.

Finally, without the changes introduced by Stock Connect, China A-shares would have a slim chance of going into global index benchmarks, like those operated by MSCI and FTSE Russell. Put simply, this index inclusion process is increasing the weight of China A-shares in global indexes and is a major driving force behind the trends of increasing foreign investor participation, improving standards, and growing flows both into and out of China's equity markets.

Given the success of the initial Stock Connect, and the growing investor appetite for China stocks, we wouldn't be surprised to see further growth in the scheme.

Big picture issues aside, operational improvements to Stock Connect can still be made.

SPSA, though a huge improvement, still requires pre-checking. Removing that would simplify trading processes further.

Also, closer alignment of trading days would be better because Shanghai, Shenzhen and Hong Kong exchanges don't always trade at the same time.

Finally, Stock Connect doesn't cover IPOs and, at time of writing, it also doesn't cover the newly launched STAR market. There are moves to include these, but as of yet we are not clear on the timeline.

Stock Connect remains a work in progress and further improvements will likely be made to improve operations and also to further expand the scope of the program.

Let's first consider the flow of overseas investors' capital into China A-shares. Northbound Stock Connect trading, meaning trading activity by Hong Kong-based investors in both the Shanghai and Shenzhen Stock Exchanges, has increased steadily since Stock Connect first launched on November 17th 2014 and total turnover reached RMB 16.5trn by end of August 20191 .

Exhibit 1: Average Daily Turnover on Stock Connect Northbound - 60 day moving average (RMB billions), Feb 16, 2015 - Sep 16, 2019

Source: Bloomberg, September 23, 2019

There's a similar picture with the flow of mainland China capital into Hong Kong. Southbound Stock Connect trading, meaning trading by mainland China-based investors on the Hong Kong Stock Exchange via Stock Connect, has also grown and total turnover came to HKD 8.52trn by the end of August 2019.

Exhibit 2: Average Daily Turnover on Stock Connect Southbound - 60 day moving average (HKD billions), Feb 16, 2015 - Sep 16, 2019

Source: Bloomberg, September 23, 2019

As flows have grown, foreign investors' share of China's A-share markets has increased. As of June 2019, foreign investors owned RMB 1.65trn (USD 230bn)3 worth of China A-shares, amounting to an estimated 7.3% of the total free-float A-share market capitalization, compared with approximately 3.2% in June 20164.

All these trends have played out because of Stock Connect, and also because it has been improved and expanded during the past five years.

Stock Connect:

  • Covers 83% of the combined market cap of the Shanghai, Shenzhen and Hong Kong Stock Exchanges;
  • Includes 1,800 companies listed on the Hong Kong, Shenzhen and Shanghai Stock Exchanges;
  • Handles average daily trading volume of HKD 64.6bn in Q2 2019, compared with HKD 7.8bn in Q1 20155

Exhibit 3: Stock Connect Average Daily Turnover (HKD Billions) Q2 2015-Q2 2019

Source: Hong Kong Exchanges & Clearing, September 2019

Singapore Retail Investors

PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY BEFORE PROCEEDING. BY UTILIZING THE WEBSITE AND PAGES THEREOF LOCATED AT WWW.UBS.COM/AM-SG ("WEBSITE"), YOU ACKNOWLEDGE THAT YOU HAVE READ THESE TERMS AS WELL AS THE GLOBAL TERMS OF USE (collectively "TERMS") AND THAT YOU AGREE TO BE BOUND BY THEM. IF YOU DO NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, YOU ARE NOT AN AUTHORIZED USER OF THESE SERVICES AND YOU SHOULD NOT USE THIS WEBSITE.

THIS WEBSITE IS NOT INTENDED FOR AND SHOULD NOT BE ACCESSED BY PERSONS LOCATED OR RESIDENT IN ANY JURISDICTION WHERE (BY REASON OF THAT PERSON'S NATIONALITY, DOMICILE, RESIDENCE OR OTHERWISE) THE PUBLICATION OR AVAILABILITY OF THIS WEBSITE IS PROHIBITED OR CONTRARY TO LOCAL LAW OR REGULATION OR WOULD SUBJECT ANY UBS ENTITY TO ANY REGISTRATION OR LICENSING REQUIREMENTS IN SUCH JURISDICTIONS.  IT IS YOUR RESPONSIBILITY TO BE AWARE OF, TO OBTAIN ALL RELEVANT REGULATORY APPROVALS, LICENCES, VERIFICATIONS AND/OR REGISTRATIONS UNDER, AND TO OBSERVE ALL APPLICABLE LAWS AND REGULATIONS OF ANY RELEVANT JURISDICTION IN CONNECTION WITH YOUR ENTRANCE TO THIS WEBSITE. EACH INVESTMENT PRODUCT AND SERVICE REFERRED TO ON THIS WEBSITE IS INTENDED TO BE MADE AVAILABLE ONLY TO RESIDENTS IN SINGAPORE.

UBS RESERVES THE RIGHT TO CHANGE, MODIFY, ADD OR REMOVE CONTENT ON THE WEBSITE AS WELL AS THESE TERMS AT ANY TIME FOR ANY REASON WITHOUT NOTICE. SUCH CHANGES SHALL BE EFFECTIVE IMMEDIATELY UPON POSTING. YOU ACKNOWLEDGE THAT BY ACCESSING OUR WEBSITE AFTER WE HAVE POSTED CHANGES TO THESE TERMS, YOU ARE AGREEING TO THESE TERMS AS MODIFIED.

The materials on this Website are distributed by UBS Asset Management (Singapore) Ltd (company registration number: 199308367C), which is licensed by Monetary Authority of Singapore ("MAS") in Singapore pursuant to the Securities and Futures Act (Chapter 289).  UBS Asset Management (Singapore) Ltd is part of the Asset Management business division of UBS Group AG. UBS Asset Management (Singapore) Ltd together with UBS Group AG and its group companies shall collectively be referred to as "UBS".

The information contained in this Website has been prepared and is intended for general circulation. The information does not constitute advice and does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products. Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy.

UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this Website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this Website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment.

This Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this Website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this Website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise)), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website have been authorised or recognised by the MAS for sale to the public in Singapore (the “Funds”). Copies of the registered Singapore prospectuses ("Prospectuses") referred to in this Website have been lodged with and registered by the MAS. The MAS assumes no responsibility for the contents of the Prospectuses. The registration of the Prospectuses by the MAS does not imply that the SFA or any other legal or regulatory requirements have been complied with.

MAS registration is not a recommendation or endorsement of a Fund nor does it guarantee the commercial merits or performance of such Fund. It does not mean that a Fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. UBS Asset Management (Singapore) Ltd has been appointed as the representative for the Funds in Singapore for the purposes of performing administrative and other related functions relating to the offer of Shares under Section 287 of the Securities and Futures Act, Chapter 289 of Singapore (the "SFA") and such other functions as the MAS may prescribe.

You may not assign your rights under the Terms without our prior written consent. UBS Asset Management (Singapore) Ltd may assign our rights under the Terms to any third party.

No person or entity who is not a party to the Terms shall have any right under the Contracts (Rights of Third Parties) Act, Chapter 53B of Singapore or other similar laws to enforce any term of the Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of the Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Singapore. The courts of Singapore shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Singapore. Each party hereby waives any objection which it might at any time have to the courts of Singapore being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2019 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

Reset